Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medtronic Inc Reaffirms FY 2013 Guidance


Tuesday, 20 Nov 2012 07:15am EST 

Medtronic Inc reiterated its fiscal 2013 guidance and expects revenue growth in the range of 2% to 4% on a constant currency basis. The Company expects fiscal 2013 diluted earnings per share (EPS) in the range of $3.62 to $3.70. The Company reported revenue of $16.184 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $16.468 billion and EPS of $3.66 for fiscal 2013 

Company Quote

68.2
0.77 +1.14%
10:56am EDT